• Anemias

Ferrlecit Generic Name & Formulations

General Description

Iron (as sodium ferric gluconate complex in sucrose) 12.5mg/mL; soln for IV inj or infusion; contains benzyl alcohol.

Pharmacological Class


How Supplied

Single-dose vials (5mL)—10


Ferrlecit Indications


Iron deficiency anemia in patients with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.

Ferrlecit Dosage and Administration


Give by IV infusion (diluted) or slow IV inj (undiluted). 125mg infused over 1 hour or by slow IV inj (at a rate of up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose.


<6yrs: not established. Give by IV infusion (diluted) over 1 hour. ≥6yrs: 1.5mg/kg per dose at 8 sequential dialysis sessions; max: 125mg/dose.

Ferrlecit Contraindications

Not Applicable

Ferrlecit Boxed Warnings

Not Applicable

Ferrlecit Warnings/Precautions


Risk of serious hypersensitivity reactions; monitor during and after administration for ≥30mins. Have personnel and resuscitative equipment readily available. Iron overload. Periodically monitor hematologic and iron parameters, and BP during and after administration. Elderly. Neonates/infants: risk of serious adverse reactions due to benzyl alcohol. Pregnancy, nursing mothers: consider alternative therapies without benzyl alcohol.

Ferrlecit Pharmacokinetics

See Literature

Ferrlecit Interactions


May reduce absorption of concomitant oral iron preparations.

Ferrlecit Adverse Reactions

Adverse Reactions

Nausea, vomiting, diarrhea, inj site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain; in children: also headache, tachycardia; hypersensitivity reactions.

Ferrlecit Clinical Trials

See Literature

Ferrlecit Note

Not Applicable

Ferrlecit Patient Counseling

See Literature